V K Rao

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Causes and consequences of the autoimmune lymphoproliferative syndrome
    V Koneti Rao
    Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10, Room 11 N228, 10 Center Drive, Bethesda, MD 20892 1888, USA
    Hematology 11:15-23. 2006
  2. ncbi Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome
    V Koneti Rao
    Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Am J Hematol 82:1049-55. 2007
  3. ncbi Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines
    T Knutsen
    Medicine Branch, Division of Clinical Sciences, NCI, National Institutes of Health, Bethesda, MD 20892, USA
    Genes Chromosomes Cancer 27:110-6. 2000

Detail Information

Publications3

  1. ncbi Causes and consequences of the autoimmune lymphoproliferative syndrome
    V Koneti Rao
    Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10, Room 11 N228, 10 Center Drive, Bethesda, MD 20892 1888, USA
    Hematology 11:15-23. 2006
    ..Thus, ALPS highlights the importance of cell death pathways in health and disease...
  2. ncbi Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome
    V Koneti Rao
    Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Am J Hematol 82:1049-55. 2007
    ..We conclude that these drugs do not warrant further use empirically or as part of clinical trials in ALPS Type Ia as a lympholytic agent...
  3. ncbi Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines
    T Knutsen
    Medicine Branch, Division of Clinical Sciences, NCI, National Institutes of Health, Bethesda, MD 20892, USA
    Genes Chromosomes Cancer 27:110-6. 2000
    ..Genes Chromosomes Cancer 27:110-116, 2000. Published 2000 Wiley-Liss, Inc...